MCHX.NASDAQMarchex INC

10-K/A: Marchex Files Amended 10-K to Include Omitted Part III Information and Correct Market Value Error

Sentiment:

10-K Amendment


Marchex has filed an amendment to its annual report on Form 10-K to include previously omitted Part III information and correct an error in the reported market value of non-affiliate equity.

Summary

  • Marchex, Inc. filed an amendment to its annual report on Form 10-K for the fiscal year ended December 31, 2023.
  • The amendment includes Part III information, which was previously omitted in reliance on a general instruction that allows incorporation by reference from the definitive proxy statement.
  • The company is filing this amendment because the definitive proxy statement will not be filed within 120 days after the fiscal year-end.
  • The amendment also corrects an error in the aggregate market value of voting and non-voting common equity held by non-affiliates as of June 30, 2023, which was previously reported incorrectly.
  • The amended filing includes restated Items 10 through 14 of Part III, and a new certification from the principal executive officer and principal financial officer.
  • This amendment does not update any other information in the original 10-K and should be read in conjunction with the original filing and subsequent SEC filings.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing with no significant positive or negative news. The sentiment is neutral to slightly positive due to the company's adherence to corporate governance standards and the overwhelming approval of its executive compensation plan by shareholders.

Positives

  • The company has a well-defined compensation program that is reviewed annually.
  • The company's compensation policies are designed to promote long-term growth in stockholder value.
  • The company has a code of conduct and ethics in place.
  • The Audit Committee is comprised of independent members, each of whom is an Audit Committee financial expert.
  • Stockholders overwhelmingly approved the executive compensation plan.

Negatives

  • The company had to file an amendment to its 10-K due to an omission of Part III information.
  • There was an error in the reported aggregate market value of non-affiliate equity.
  • The company's 2014 Employee Stock Purchase Plan expired on December 31, 2023.

Risks

  • The company's success depends on its ability to retain its management team.
  • The company's compensation programs are weighted towards long-term incentives, which may not align with short-term market fluctuations.
  • The company's equity awards are subject to vesting conditions and may be forfeited if employment is terminated.
  • The company's financial performance and stock price can impact the value of equity awards.

Future Outlook

The document does not contain specific forward-looking statements or guidance, but it does outline the company's compensation and equity plans, which are designed to incentivize long-term growth and performance.

Management Comments

  • The Compensation Committee believes this affirms the stockholders support of our approach to executive compensation and did not change its approach in 2023.
  • The Compensation Committee will continue to consider the outcome of our say-on-pay votes when making future compensation decisions for the named executive officers.

Industry Context

This filing is a routine amendment to a company's annual report, focusing on corporate governance and executive compensation. It does not indicate any significant shifts in the company's business strategy or market position. The company operates in the technology sector, and its compensation practices are compared to those of other public media, internet, and technology-based companies.

Comparison to Industry Standards

  • Marchex's compensation practices are reviewed against those of public media, internet, and technology-based companies of comparable size.
  • The company does not benchmark its compensation to any particular level but uses competitor data for perspective.
  • The company's equity compensation plans are similar to those of other public companies, offering stock options, restricted stock, and restricted stock units.
  • The company's board structure and committee composition are in line with NASDAQ listing standards for corporate governance.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
CEOOffice of the CEOEdwin MillerFebruary 2023Appointment of new CEO
Chief Revenue OfficerJohn RoswechTroy HartlessApril 2023Appointment of new CRO
Chief Financial OfficerNAHolly AglioOctober 2023Appointment of new CFO

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Audit Committee CompositionThe Audit Committee is comprised of Messrs. Cline, Cogsville and Wisehart, each of whom is independent and an Audit Committee financial expert.OngoingEnsures compliance with NASDAQ listing standards and SEC rules.
Code of Conduct and EthicsThe company has adopted a code of conduct and a code of ethics, available on the company website.OngoingPromotes ethical behavior and compliance with regulations.

Stakeholder Impact

  • Shareholders are impacted by the company's compensation policies and equity plans.
  • Employees are impacted by the company's compensation and equity plans.
  • The company's financial performance impacts the value of equity awards.

Next Steps

  • The company will continue to operate under its existing compensation and equity plans.
  • The company will continue to file required reports with the SEC.
  • The company will hold its 2024 Annual Meeting of Stockholders.

Key Dates

DateDescription
May 4, 2012The 2012 Stock Incentive Plan was adopted by the Board of Directors and approved by stockholders.
May 3, 2013The 2014 Employee Stock Purchase Plan was adopted by the Board of Directors and approved by stockholders.
October 1, 2021The 2021 Stock Incentive Plan was adopted by the Board of Directors and approved by stockholders.
November 11, 2022The Audit Committee approved the selection of RSM US LLP as Marchex's independent registered public accounting firm.
December 31, 2023Fiscal year ended and the 2014 Employee Stock Purchase Plan expired.
April 1, 2024Original Form 10-K was filed with the SEC.
April 25, 2024Number of shares of Class A and Class B common stock outstanding as of this date.
April 29, 2024Date of filing of this Amendment No. 1 to the Annual Report on Form 10-K.

Keywords

Marchex, 10-K, Amendment, Executive Compensation, Corporate Governance, Stock Options, Restricted Stock, Directors, Audit Committee, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.